{"id":993,"date":"2025-12-09T15:45:45","date_gmt":"2025-12-09T15:45:45","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/12\/09\/fda-gives-tentative-approval-to-generic-siponimod-tablets-for-ms\/"},"modified":"2025-12-09T15:45:45","modified_gmt":"2025-12-09T15:45:45","slug":"fda-gives-tentative-approval-to-generic-siponimod-tablets-for-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/12\/09\/fda-gives-tentative-approval-to-generic-siponimod-tablets-for-ms\/","title":{"rendered":"FDA gives tentative approval to generic Siponimod tablets for MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/09\/fda-gives-tentative-approval-generic-siponimod-tablets-ms\/\" title=\"FDA gives tentative approval to generic Siponimod tablets for MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2024\/12\/thumbsup_700x350-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Multiple hands are seen giving the thumbs-up sign from inside a black circle.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"144062\" \/><\/a><\/p>\n<p>The\u00a0U.S. Food and Drug Administration\u00a0(FDA) has given tentative approval to\u00a0Lupin\u2019s Siponimod tablets, a bioequivalent version of Mayzent (siponimod), to treat people with relapsing forms of\u00a0multiple sclerosis (MS). According to a company press release, the therapy is indicated for use in adults with clinically isolated syndrome, relapsing-remitting MS (RRMS), or active secondary progressive MS (SPMS). Similar [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/09\/fda-gives-tentative-approval-generic-siponimod-tablets-ms\/\">FDA gives tentative approval to generic Siponimod tablets for MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/09\/fda-gives-tentative-approval-generic-siponimod-tablets-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The\u00a0U.S. Food and Drug Administration\u00a0(FDA) has given tentative approval to\u00a0Lupin\u2019s Siponimod tablets, a bioequivalent version of Mayzent (siponimod), to treat people with relapsing forms of\u00a0multiple sclerosis (MS). According to a company press release, the therapy is indicated for use in adults with clinically isolated syndrome, relapsing-remitting MS (RRMS), or active secondary progressive MS (SPMS). Similar&#8230;<\/p>\n","protected":false},"author":0,"featured_media":994,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-993","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=993"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/993\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/994"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}